Pharmabiz3h
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...
Pharmabiz42m
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz5h
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...
Pharmabiz2h
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...
Pharmabiz2h
Impose 5-15% duty on imports of medical devices and monitor MRP against import landed cost, demands AiMeD
Our Bureau, New Delhi Friday, January 10, 2025, 16:10 Hrs [IST] ...
Pharmabiz1h
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner: Manila, Philippines Friday, January 10, 2025, 17:00 Hrs [IST] Zuellig Pharma, a leading healthcare solu ...
Pharmabiz2h
AI to revolutionise hair loss diagnosis and treatment, say experts
AI to revolutionise hair loss diagnosis and treatment, say experts: Our Bureau, New Delhi Friday, January 10, 2025, 16:20 Hrs [IST] The integration of AI marks a significant leap ...
Pharmabiz2h
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development: Incheon, S. Korea Friday, January 10, 2025, 16:00 Hrs [IST] Samsung Biologics, a global cont ...
Pharmabiz3h
Dr Sunita Tandulwadkar takes over as 63rd FOGSI president, unveils bold vision for transforming women’s healthcare in India
Our Bureau, Mumbai Friday, January 10, 2025, 14:45 Hrs [IST] ...
Pharmabiz3h
Medi Assist’s 2024 findings shed light on rising costs, incidence and demography wise hospitalisation patterns
Our Bureau, Mumbai Friday, January 10, 2025, 15:40 Hrs [IST] ...
Pharmabiz3h
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...
Pharmabiz3h
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...